RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
TQVIX
Price
$22.75
Change
+$0.13 (+0.57%)
Updated
Jul 31 closing price
Net Assets
91.5M
Interact to see
Advertisement

RMEBX vs TQVIX

RMEBX vs TQVIX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. TQVIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and TQVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. TQVIX (91.5M). TQVIX pays higher dividends than RMEBX: TQVIX (1.29) vs RMEBX (0.99). RMEBX was incepted earlier than TQVIX: RMEBX (12 years) vs TQVIX (10 years). RMEBX (1.07) and TQVIX (1.07) have similar cost to investors . TQVIX is a more actively managed with annual turnover of: 87.60 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than TQVIX: RMEBX (250) vs TQVIX (500000). TQVIX annual gain was more profitable for investors over the last year : 27.00 vs. RMEBX (8.96). TQVIX return over 5 years is better than : 51.93 vs. RMEBX (36.13).
RMEBXTQVIXRMEBX / TQVIX
Total Expense Ratio1.070.53202%
Annual Report Gross Expense Ratio1.071.07100%
Fund Existence12 years10 years-
Gain YTD9.41620.24347%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets118B91.5M128,962%
Annual Yield % from dividends0.991.2977%
Returns for 1 year8.9627.0033%
Returns for 3 years32.6343.9474%
Returns for 5 years36.1351.9370%
Returns for 10 years90.64138.5165%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A